New drug trial offers hope for Tough-to-Treat skin cancer patients

NCT ID NCT06854653

Summary

This study is testing an experimental drug called PTX-100 for adults with cutaneous T-cell lymphoma that has returned or hasn't responded to at least two previous treatments. Participants receive PTX-100 through IV infusions in repeating cycles for up to 18 months. The main goal is to see how well the drug shrinks tumors and controls the disease while monitoring side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CTCL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Bordeaux - Hopital Saint André

    NOT_YET_RECRUITING

    Bordeaux, Bordeaux, 33000, France

    Contact Phone: •••-•••-••••

    Contact

  • City of Hope Comprehensive Cancer Cente

    RECRUITING

    Duarte, California, 91010, United States

    Contact

    Contact Phone: •••-•••-••••

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 022155450, United States

    Contact Phone: •••-•••-••••

    Contact

  • Epworth Healthcare

    RECRUITING

    Melbourne, Victoria, 3002, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hopital Lyon Sud

    NOT_YET_RECRUITING

    Lyon, Pierre-Benite, 69310, France

    Contact Phone: •••-•••-••••

    Contact

  • Hopital Saint Louis

    NOT_YET_RECRUITING

    Paris, Île-de-France Region, 75010, France

    Contact Phone: •••-•••-••••

    Contact

  • IRCCS Azienda Ospedaliero Universitaria di Bologna - Policlinico S. Orsola-Malpighi

    RECRUITING

    Bologna, Bologna, 40138, Italy

    Contact Phone: •••-•••-••••

    Contact

  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele)

    NOT_YET_RECRUITING

    Milan, Milano, 20132, Italy

    Contact Phone: •••-•••-••••

    Contact

  • Linear Clinical Research

    RECRUITING

    Nedlands, Western Australia, 6009, Australia

    Contact Phone: •••-•••-••••

    Contact

  • Rochester Skin Lymphoma Medical Group. PLLC

    RECRUITING

    Rochester, New York, 14642, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Universita degli Studi Di Brescia-Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

    RECRUITING

    Brescia, Brescia, 25123, Italy

    Contact Phone: •••-•••-••••

    Contact

  • University of California Irvine

    RECRUITING

    Irvine, California, 92697, United States

    Contact Phone: •••-•••-••••

    Contact

  • Virginia Commonwealth University Massey Comprehensive Cancer Cente

    RECRUITING

    Richmond, Virginia, 980037, United States

    Contact Phone: •••-•••-••••

    Contact

  • Westmead Hospital

    RECRUITING

    Westmead, New South Wales, 2145, Australia

    Contact Phone: •••-•••-••••

    Contact

  • Yale Cancer Center

    RECRUITING

    New Haven, Connecticut, 06510, United States

    Contact Phone: •••-•••-••••

    Contact

Conditions

Explore the condition pages connected to this study.